Results 271 to 280 of about 219,337 (367)
Narrative review of strategies for blood product shelf‐life extension
Transfusion, EarlyView.
Mike Akaraphanth +7 more
wiley +1 more source
Mechanism of rupture hemorrhage in cerebral cavernous malformations. Environmental and immune factors promote the progression of lesions and induce the risk of abnormal formation or rupture of cerebrovascular vessels. Abstract Purpose of Review To review how the immune microenvironment and oxidative stress modulate the initiation, maturation, and ...
Xuesai Zhu +3 more
wiley +1 more source
Beyond lipids: Systemic effects of lipoprotein apheresis
Transfusion, EarlyView.
Menatalla Nadim, Yamac Akgun
wiley +1 more source
Heyde Syndrome: A Literature Review
ABSTRACT Background and Aims Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement.
Yashika Gupta +12 more
wiley +1 more source
Uniaxial cyclic stretch regulates the expression of thrombomodulin and von Willebrand factor on endothelial cells. [PDF]
Giannetti A +8 more
europepmc +1 more source
Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
A A Novikov +7 more
openalex +1 more source
ABSTRACT Background Sarcopenia is an age‐related degenerative disorder characterized by a progressive decline in skeletal muscle mass, strength, and function with high prevalence in chronic kidney disease (CKD). Identifying clinical and epidemiological factors of sarcopenia in patients with CKD is essential to enable early recognition and appropriate ...
Kaili Jin +6 more
wiley +1 more source
Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Treated With Recombinant von Willebrand Factor in Surgical Settings in the United Kingdom. [PDF]
Laffan M +6 more
europepmc +1 more source
von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.
Y. Sanders +11 more
semanticscholar +1 more source
ABSTRACT Background Large B‐cell lymphomas (LBCLs) are a common subtype of non‐Hodgkin lymphomas. CD19 chimeric antigen receptor T‐cell (CAR‐T) therapy has revolutionized LBCL treatment, with high remission rates but also significant toxicities, including cytokine release syndrome (CRS) and immune effector cell‐associated neurotoxicity syndrome (ICANS).
Neha Venkatesh +9 more
wiley +1 more source

